AIOT vs ASML

AIOT exhibits weak financial health per the Piotroski F-Score of 2/9, indicating significant operational and profitability concerns. The absence of an Altman Z-Score raises distress risk concerns, particularly given negative ROE (-6.43%) and inconsistent earnings performance. While the stock trades at a modest Price/Book of 0.86 and Price/Sales of 0.97, suggesting potential undervaluation, this is undermined by persistent losses, erratic earnings surprises (average -264.29% over last 4 quarters), and a 52-week range near its low. The lack of analyst consensus and neutral insider activity further dampen conviction.

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.